Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

HCC Profiles

Hepatocellular carcinoma (HCC) requires thorough evaluation of the tumor stage to ensure precise prognosis and clear treatment recommendations, including consideration of liver transplantation. To achieve this goal, patient assessment must be based on both radiological and clinical parameters. The new HCC staging support in mint Lesion™ 3.0 therefore allows to easily capture a number of relevant imaging parameters (e.g. size, number, vascular invasion) and clinical data (e.g. Child-Pugh score and Performance Status). Based on these parameters, mint Lesion™ 3.0 automatically derives BCLC and TNM staging as well as liver transplantation recommendations according to Milan or UCSF criteria.

 

Related Resources

Related Resources

Mint Medical and Agfa HealthCare announce seamless integration of mint Lesion and ORBIS RIS at RSNA 2018

Heidelberg, Bonn, GER - At this year’s Radiological Society of North America (RSNA) Annual Meeting 2018, Agfa HealthCare and Mint Medical will…

mint PI-RADS V2 report as the standard for communication with urologists - Interview with PD Dr. Röthke

Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion™ by PD Dr. Matthias Röthke, Chief Medical Officer at…

Pancreas staging in clinical routine at University Hospital Innsbruck - Interview with PD Dr. Widmann

The University Hospital in Innsbruck, Austria, has been using mint Lesion™ since mid-2015 with the initial focus on clinical trials in order to…